SEM1 and neuroblastoma: Cisplatin-chemoresistant neuroblastoma cells have been found to show high expression levels of SHFM1 (i.e., 26S proteasome complex subunit SEM1) and PSMD14 (i.e., 26S proteasome non-ATPase regulatory subunit 14) using transcriptomic profiling [184].